UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy-Are 2 Biopsy Cores per Magnetic Resonance Imaging Lesion Required?

The Journal of urology, 2018-11, Vol.200 (5), p.1030

2018

Link zum Volltext

Verfügbarkeit prüfen

Treatment of clinical stage I non-seminoma

Asian Journal of Urology, 2021-04, Vol.8 (2), p.161-169

2021

Link zum Volltext

Verfügbarkeit prüfen

Surgical treatment of metastatic germ cell cancer

Asian Journal of Urology, 2021-04, Vol.8 (2), p.155-160

2021

Link zum Volltext

Verfügbarkeit prüfen

Management, Treatment, and Molecular Background of the Growing Teratoma Syndrome

Urologic clinics of North America, 2019-08, Vol.46 (3), p.419

2019

Link zum Volltext

Verfügbarkeit prüfen

The use of targeted MR-guided prostate biopsy reduces the risk of Gleason upgrading on radical prostatectomy

Journal of cancer research and clinical oncology, 2015-11, Vol.141 (11), p.2061-2068

2015

Link zum Volltext

Verfügbarkeit prüfen

Feasibility of diffusional kurtosis tensor imaging in prostate MRI for the assessment of prostate cancer: Preliminary results

Magnetic resonance imaging, 2014-09, Vol.32 (7), p.880-885

2014

Link zum Volltext

Verfügbarkeit prüfen

Comparison of patient comfort between MR-guided in-bore and MRI/ultrasound fusion-guided prostate biopsies within a prospective randomized trial

World journal of urology, 2016-02, Vol.34 (2), p.215-220

2016

Link zum Volltext

Verfügbarkeit prüfen

Preservation of Ejaculatory Function After Postchemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND) in Patients With Testicular Cancer: Template vs. Bilateral Resection

Frontiers in surgery, 2019-01, Vol.5, p.80-80

2019

Link zum Volltext

Verfügbarkeit prüfen

Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study

Therapeutic advances in medical oncology, 2022-03, Vol.14, p.17588359221086813-17588359221086813

2022

Link zum Volltext

Verfügbarkeit prüfen

Reply to Kirti Singh, Swarnendu Mandal, Manoj Kumar Das, Prasant Nayak, and Sambit Tripathy’s Letter to the Editor re: Andreas Hiester, Yue Che, Achim Lusch, et al. Phase 2 Single-arm Trial of Primary Retroperitoneal Lymph Node Dissection in Patients with Seminomatous Testicular Germ Cell Tumors with Clinical Stage IIA/B (PRIMETEST). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.10.021

European urology, 2023-06, Vol.83 (6), p.e157-e157

2023

Link zum Volltext

Verfügbarkeit prüfen

Editorial Comment

The Journal of urology, 2020-05, Vol.203 (5), p.955

Hiester, Andreas

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 Single-arm Trial of Primary Retroperitoneal Lymph Node Dissection in Patients with Seminomatous Testicular Germ Cell Tumors with Clinical Stage IIA/B (PRIMETEST)

European urology, 2023-07, Vol.84 (1), p.25-31

2023

Link zum Volltext

Verfügbarkeit prüfen

Adjunctive Surgery Is Often Without Oncological Benefit at Time of Postchemotherapy Retroperitoneal Lymph Node Dissection

The Journal of urology, 2024-03, Vol.211 (3), p.426

2024

Link zum Volltext

Verfügbarkeit prüfen

Prospective Randomized Trial Comparing Magnetic Resonance Imaging (MRI)-guided In-bore Biopsy to MRI-ultrasound Fusion and Transrectal Ultrasound-guided Prostate Biopsy in Patients with Prior Negative Biopsies

European urology, 2015-10, Vol.68 (4), p.713-720

2015

Link zum Volltext

Verfügbarkeit prüfen

Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen

The Journal of urology, 2014-11, Vol.192 (5), p.1374

2014

Link zum Volltext

Verfügbarkeit prüfen

Need for organ preservation in postchemotherapy retroperitoneal lymph node dissection (PC-RPLND)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.5031-5031

2022

Link zum Volltext

Verfügbarkeit prüfen

Therapiemöglichkeiten des Seminoms im klinischen Stadium I und II unter Berücksichtigung der Langzeittoxizität

Der Onkologe, 2021, Vol.27 (1), p.5-12

2021

Link zum Volltext

Verfügbarkeit prüfen

The PRIMETEST trial: Prospective phase II trial of primary retroperitoneal lymph node dissection (RPLND) in stage II A/B patients with seminoma

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.420-420

2022

Link zum Volltext

Verfügbarkeit prüfen

The PRIMETEST trial: Interim analysis of a phase II trial for primary retroperitoneal lymph node dissection (RPLND) in stage II A/B seminoma patients without adjuvant treatment

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.507-507

2019

Link zum Volltext

Verfügbarkeit prüfen

MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy

European radiology, 2014-10, Vol.24 (10), p.2582-2589

2014

Link zum Volltext

Verfügbarkeit prüfen

Aktuelle Entwicklungen und Behandlungsmöglichkeiten für das Growing-Teratoma-Syndrom

Der Onkologe, 2021, Vol.27 (1), p.21-28

2021

Link zum Volltext

Verfügbarkeit prüfen

Postchemotherapy Residual Tumor Resection in Patients with Elevated Tumor Markers

The Journal of urology, 2022-03, Vol.207 (3), p.617

2022

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the oncologic benefit of adjunctive surgery at time of postchemotherapy retroperitoneal lymph node dissection (PC-RPLND)

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.388-388

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(46)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy-Are 2 Biopsy Cores per Magnetic Resonance Imaging Lesion Required?

Treatment of clinical stage I non-seminoma

Surgical treatment of metastatic germ cell cancer

Management, Treatment, and Molecular Background of the Growing Teratoma Syndrome

The use of targeted MR-guided prostate biopsy reduces the risk of Gleason upgrading on radical prostatectomy

Feasibility of diffusional kurtosis tensor imaging in prostate MRI for the assessment of prostate cancer: Preliminary results

Comparison of patient comfort between MR-guided in-bore and MRI/ultrasound fusion-guided prostate biopsies within a prospective randomized trial

Preservation of Ejaculatory Function After Postchemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND) in Patients With Testicular Cancer: Template vs. Bilateral Resection

Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study

Editorial Comment

Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer

Phase 2 Single-arm Trial of Primary Retroperitoneal Lymph Node Dissection in Patients with Seminomatous Testicular Germ Cell Tumors with Clinical Stage IIA/B (PRIMETEST)

Adjunctive Surgery Is Often Without Oncological Benefit at Time of Postchemotherapy Retroperitoneal Lymph Node Dissection

Prospective Randomized Trial Comparing Magnetic Resonance Imaging (MRI)-guided In-bore Biopsy to MRI-ultrasound Fusion and Transrectal Ultrasound-guided Prostate Biopsy in Patients with Prior Negative Biopsies

Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen

Need for organ preservation in postchemotherapy retroperitoneal lymph node dissection (PC-RPLND)

Therapiemöglichkeiten des Seminoms im klinischen Stadium I und II unter Berücksichtigung der Langzeittoxizität

The PRIMETEST trial: Prospective phase II trial of primary retroperitoneal lymph node dissection (RPLND) in stage II A/B patients with seminoma

The PRIMETEST trial: Interim analysis of a phase II trial for primary retroperitoneal lymph node dissection (RPLND) in stage II A/B seminoma patients without adjuvant treatment

MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy

Aktuelle Entwicklungen und Behandlungsmöglichkeiten für das Growing-Teratoma-Syndrom

Postchemotherapy Residual Tumor Resection in Patients with Elevated Tumor Markers

Evaluation of the oncologic benefit of adjunctive surgery at time of postchemotherapy retroperitoneal lymph node dissection (PC-RPLND)

Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought

Suchergebnisse filtern